期刊文献+

地高辛标记探针检测重组RMBAYL多肽DNA残留量的研究

Study of Residual DNA in Recombinant RMBAYL by Using Digoxin Labeled Probe
原文传递
导出
摘要 为了建立标记探针检测基因重组RMBAYL多肽DNA残留量的方法,以基因重组技术和固相柱纯化技术制备重组PACAP衍生多肽RMBAYL,以工程菌总DNA为模板,用地高辛标记探针,以此探针杂交并进行显色反应。实验结果表明,3批重组RMBAYL半成品中每人份剂量的外源性DNA残留量均小于100 Pg。研究的实验方案可实现重组PACAP衍生多肽RMBAYL的高效表达和纯化,地高辛标记探针技术检测外源性DNA灵敏度高、稳定性强,可用于RMBAYL等重组PACAP衍生多肽制备过程中的质量监控及半成品的快速、高效检定。 To determine the residual DNA in recombinant RMBAYL by using digoxin labeled probe and establish a method for analyzing the residual DNA in recombinant PACAP derived peptide, recombinant RMBAYL was prepared by genetic engineering technique and solid-phase purification technique. Total DNA of engineering bacteria of recombinant RMBAYL was labeled by digoxin and used as probe for hybridization assay of residual DNA in semi-finished products of recombinant RMBAYL for injection. The experiment results showed that the residual DNA in three batches of semi-finished products was less than 100pg per dosage for one person. The current methods not only could achieve highly efficient expression and purification of recombinant RMBAYL, but also digoxin labeled probe method for determining residual DNA in recombinant RMBAYL had high sensitivity and stability and it could be used for the quality control of recombinant PACAP derived peptide or specific, rapid and efficient detection of semi-finished products.
出处 《药物生物技术》 CAS CSCD 2009年第6期540-544,共5页 Pharmaceutical Biotechnology
基金 国家高技术研究发展计划("863计划")(2006AA02Z125) 广东省重大专项(2007A032100006) 广东省自然科技基金资助项目(No:9451063201002336) 中国博士后科学基金资助项目(20090460785) "211工程"Ⅲ期项目
关键词 地高辛 DNA残留量 基因重组 PACAP衍生多肽 Digoxin, Residual DNA, Gene recombination, PACAP derived peptide
  • 相关文献

参考文献4

二级参考文献15

  • 1Rong-jieYU AnHONG YunDAI YuanGAO.Intein-mediated Rapid Purification of Recombinant Human Pituitary Adenylate Cyclase Activating Polypeptide[J].Acta Biochimica et Biophysica Sinica,2004,36(11):759-766. 被引量:3
  • 2郑荣,胡毅,朱春宝,朱宝泉,史炳照.白细胞介素-2基因在质粒pMAL-cR1中的克隆及其蛋白的表达与纯化[J].中国医药工业杂志,1994,25(6):243-246. 被引量:3
  • 3刘学博,李胜华,梁小兵,孔祥英.一个高效表达且纯化简单的重组蛋白载体系统[J].军事医学科学院院刊,1996,20(1):62-65. 被引量:2
  • 4冯丹,袁勇,张颖妹,冯岚,范慧,狄春辉,宋泉声,马大龙.枸橼酸酐对原核表达重组GM-CSF的修饰作用[J].生物化学与生物物理进展,1996,23(6):541-544. 被引量:1
  • 5Ghzili H, Grumolato L, Thou? nnon E, et al. Role of PACAP in the physiology and pathology of the sympathoadrenal system. Front Neuroendocrinol, 2008, 29 ( 1 ) :128 ~ 141
  • 6Winzell M S, Ahren B. Role of VIP and PACAP in islet function. Peptides, 2007, 28(9):1805- 1813
  • 7Pan C Q, Li F, Tom I, et al. Engineering novel VPAC2-selective agonists with improved stability and glucose-lowering activity in vivo. J Pharmacol Exp Ther, 2007, 320 ( 2 ) : 900-906
  • 8Yung S L, Cruz F D, Hamren S, et al. Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclaseactivating peptide. J Biol Chem, 2003, 278 (12) : 10273 - 10281
  • 9Tsutsumi M, Claus T H, Liang Y, et al. A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal, a potential therapy for type 2 diabetes. Diabetes, 2002, 51 (5) : 1453 - 1460
  • 10Yu R J, Xie Q L, Dai Y, et al. Intein-mediated rapid purification and characterization of a novel recombinant agonist for VPAC2. Peptides, 2006, 27 (6) :1359 -1366

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部